Advanced search
Publication Cover
Modern Rheumatology Volume 16, 2006 - Issue 6
Journal homepage
43
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Efficacy profile of bucillamine in rheumatoid arthritis patients in a large observational cohort study, IORRA

Masako IwataniInstitute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjiku-ku, Tokyo 162-0054, Japan
,
Eisuke InoueInstitute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjiku-ku, Tokyo 162-0054, Japan
,
Takahiro NakamuraInstitute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjiku-ku, Tokyo 162-0054, Japan
,
Ayako NakajimaInstitute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjiku-ku, Tokyo 162-0054, Japan
,
Masako HaraInstitute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjiku-ku, Tokyo 162-0054, Japan
,
Taisuke TomatsuInstitute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjiku-ku, Tokyo 162-0054, Japan
,
Naoyuki KamataniInstitute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjiku-ku, Tokyo 162-0054, Japan
&
Hisashi YamanakaInstitute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjiku-ku, Tokyo 162-0054, JapanCorrespondence[email protected]
 show all
Pages 376-380 | Received 12 Jul 2006, Accepted 11 Sep 2006, Published online: 02 Jan 2014

References

  • American College of Rheumatology Subcommittee on Rheuma-toid Arthritis Guidelines. Guidelines for the Management of Rheumatoid Arthritis. 2002 Update. Arthritis Rheum 2002;46(2): 328–46.
  • van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, vander Veen MJ, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs. A ran-domized, controlled trial. Ann Intern Med 1996;124(8):699–707.
  • Stenger AA, Van Leeuwen MA, Houtman PM, Bruyn GA, Speerstra F, Barendsen BC, et al. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic pro-gression. Br J Ftheumatol 1998;37(11):1157–63.
  • Abe C. Clinical evaluation of immunomodulators. Int J Immun-other 1985;1:7–10.
  • Kashiwazaki S, Shiokawa Y. Bucillamine: a new immunomo-dulator. Int J Immunother 1987;3:1–6.
  • Matsuno H, Sugiyama E, Muraguchi A, Nezuka T, Kubo T, Matsuura K, et al. Pharmacological effects of 5A96 (bucillamine) and its metabolites as immunomodulating drugs - the disulfide structure of SA-96 metabolites plays a critical role in the pharma-cological action of the drug. Int J Immunopharmacol 1998;20(6): 295–304.
  • Hirohata S, Lipsky PE. Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cells. Arthritis Rheum 1994;37(6):942–50.
  • Hirohata S, Lipsky PE. Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug. Clin Immunol Immunopathol 1993;66(1):43–51.
  • Takai M, Odani N, Tanimoto Y, Aono H, Shimomura K. The effects of bucillamine and salazosulfapyridine on the joint destruc-tion in rheumatoid arthritis. Med Sci Dig 2002;28(11):450–3.
  • Sekiguchi N, Kameda H, Amano K, Takeuchi T. Efficacy and safety of bucillamine, a D-penicillamine analogue, in patients with active rheumatoid arthritis. Mod Ftheumatol 2006;16(2):85–91.
  • Nagashima M, Shu G, Yamamoto K, Yamahatsu S, Yoshino S. The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. Epi-demiology of DMARDs treatment in Japan. Clin Exp Ftheumatol 2005;23(1):27–35.
  • Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, et al. Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3763 patients with rheuma-toid arthritis. Arthritis Rheum 2003;49(6):784–8.
  • Yamanaka H, Tohma S. Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice. Mod Ftheumatol 2006;16(2):75–6.
  • Furst DE. Observational cohort studies and well controlled clinical trials - we need them both! J Ftheumatol 2004;31(8):1476–7.
  • van der Heijde DMFM, van Ftiel PLCM, Leeuwen MA, van 't Hof MA, van Rijswijk MH, van de Putte LBA. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Ftheumatol 1992;31: 519–25.
  • Ichikawa Y, Saito T, Yamanaka H, Akizuki M, Kondo H, Kobayashi S, et al. Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study. Mod Ftheumatol 2005;15:323–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.